Fenofibrate Shows Promise in Slowing Diabetic Retinopathy Progression

NEJM Evid. 2024 Aug;3(8):EVIDe2400205. doi: 10.1056/EVIDe2400205. Epub 2024 Jul 23.

Authors

Paolo S Silva^{1

2}, Lloyd Paul Aiello^{1

2}

Affiliations

¹ Department of Ophthalmology, Harvard Medical School, Boston.
² Beetham Eye Institute, Joslin Diabetes Center, Boston.

PMID: 39041872
DOI: 10.1056/EVIDe2400205

No abstract available

Publication types

News
Editorial
Comment

MeSH terms

Diabetic Retinopathy* / drug therapy
Disease Progression*
Fenofibrate* / pharmacology
Fenofibrate* / therapeutic use
Humans
Hypolipidemic Agents* / pharmacology
Hypolipidemic Agents* / therapeutic use

Substances

Fenofibrate
Hypolipidemic Agents